PortfoliosLab logo

Angion Biomedica Corp. (ANGN)

Equity · Currency in USD · Last updated Dec 10, 2022

Company Info

ISINUS03476J1079
CUSIP03476J107
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.83
Year Range$0.81 - $2.96
EMA (50)$0.92
EMA (200)$1.47
Average Volume$63.69K
Market Capitalization$25.06M

ANGNShare Price Chart


Loading data...

ANGNPerformance

The chart shows the growth of $10,000 invested in Angion Biomedica Corp. in Feb 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $489 for a total return of roughly -95.11%. All prices are adjusted for splits and dividends.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
-52.71%
4.92%
ANGN (Angion Biomedica Corp.)
Benchmark (^GSPC)

ANGNCompare to other instruments

Search for stocks, ETFs, and funds to compare with ANGN

ANGNReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-4.36%2.78%
6M-51.90%-2.08%
YTD-71.31%-17.45%
1Y-76.82%-16.31%
5Y-80.52%0.66%
10Y-80.52%0.66%

ANGNMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-6.90%-31.11%13.98%-41.04%40.80%-35.23%-5.26%-5.56%-9.80%8.70%-15.21%-1.86%
20211.88%4.21%-21.80%9.27%-15.67%-18.36%3.57%-11.26%-57.32%-13.67%-19.44%

ANGNSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Angion Biomedica Corp. Sharpe ratio is -0.74. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.20JulyAugustSeptemberOctoberNovemberDecember
-0.74
-0.65
ANGN (Angion Biomedica Corp.)
Benchmark (^GSPC)

ANGNDividend History


Angion Biomedica Corp. doesn't pay dividends

ANGNDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember
-96.77%
-17.97%
ANGN (Angion Biomedica Corp.)
Benchmark (^GSPC)

ANGNWorst Drawdowns

The table below shows the maximum drawdowns of the Angion Biomedica Corp.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Angion Biomedica Corp. is 96.85%, recorded on Nov 9, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.85%Feb 23, 2021434Nov 9, 2022
-1.48%Feb 9, 20211Feb 9, 20212Feb 11, 20213

ANGNVolatility Chart

Current Angion Biomedica Corp. volatility is 87.81%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%300.00%JulyAugustSeptemberOctoberNovemberDecember
87.81%
22.29%
ANGN (Angion Biomedica Corp.)
Benchmark (^GSPC)